2003•Unpublished venueRequires access

Immune tolerance induction by IL-10 modified dendritic cells in rat small bowel transplantation

Min Zhu

Open publisher page 0 citations

Abstract

Objective To study the effect of allograft immune tolerance induction by donor IL-10-modified dendritic cells (DC)for providing theoretical and practical basis for anti-rejection of small bowel transplantation. Methods The recipient was pretreated with donor IL-10-treated DC or with untreated DC. Small bowel transplantation was performed and the survival time of small bowel allografts were observed. Results The survival time in the groups of control, untreated DC and IL-10-treated DC was ( 7.33 ± 2.42 ) days, ( 8.33 ± 2.94 ) days and ( 18.5 ± 5.17 ) days respectively. Statistical analysis showed that there was no obvious difference between untreated DC and control groups. However, the survival time of small bowel allografts in IL-10-treated DC group was significantly different from that in control group ( P 0.01 ).Conclusion The pretreatment with donor IL-10-treated DC can prolong the survival time of rat small bowel allografts after transplantation.

About this research paper

What this paper is about

Objective To study the effect of allograft immune tolerance induction by donor IL-10-modified dendritic cells (DC)for providing theoretical and practical basis for anti-rejection of small bowel transplantation. Methods The recipient was pretreated with donor IL-10-treated DC or with untreated DC. Small bowel transplantation was performed and the survival time of small bowel allografts were observed. Results The survival time in the groups of control, untreated DC and IL-10-treated DC was ( 7.33 ± 2.42 ) days, ( 8.33 ± 2.94 ) days and ( 18.5 ± 5.17 ) days respectively. Statistical analysis showed that there was no obvious difference between untreated DC and control groups. However, the survival time of small bowel allografts in IL-10-treated DC group was significantly different from that in control group ( P 0.01 ).Conclusion The pretreatment with donor IL-10-treated DC can prolong the survival time of rat small bowel allografts after transplantation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of allograft immune tolerance induction by donor IL-10-modified dendritic cells (DC)for providing theoretical and practical basis for anti-rejection of small bowel transplantation. Methods The recipient was pretreated with donor IL-10-treated DC or with untreated DC. Small bowel transplantation was performed and the survival time of small bowel allografts were observed. Results The survival time in the groups of control, untreated DC and IL-10-treated DC was ( 7.33 ± 2.42 ) days, ( 8.33 ± 2.94 ) days and ( 18.5 ± 5.17 ) days respectively. Statistical analysis showed that there was no obvious difference between untreated DC and control groups. However, the survival time of small bowel allografts in IL-10-treated DC group was significantly different from that in control group ( P 0.01 ).Conclusion The pretreatment with donor IL-10-treated DC can prolong the survival time of rat small bowel allografts after transplantation.

Key concepts: Transplantation, Medicine, Immune system, Immune tolerance, Gastroenterology, Dendritic cell, Internal medicine, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Immune tolerance induction by IL-10 modified dendritic cells in rat small bowel transplantation — Research Paper | ScholarLens